Teng Yu
Metabolic reprogramming is a hallmark of cancer, driving cellular proliferation and survival. This research delves into the intricate metabolic pathways within cancer cells and their implications for clinical practice. Through a comprehensive review of current literature and experimental data, we elucidate the dysregulated metabolic processes that underpin cancer progression. Furthermore, we discuss the potential therapeutic targets emerging from this understanding and their application in clinical settings. This exploration of metabolic pathways in cancer cells provides critical insights for developing innovative strategies for cancer diagnosis, prognosis and treatment.
分享此文章
English 
Spanish 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 